Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15136438 | Publishing Date : 29-Jan-2020 | No. of pages : 94
Detailed TOC of Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue
1.4 Market Analysis by Type
1.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lung Cancer
1.4.3 Colorectal Cancer
1.4.4 Breast Cancer
1.4.5 Others
1.5 Market by Application
1.5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Research Institutes and Research Institutions
1.5.4 Clinic
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Perspective (2015-2026)
2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Regions
2.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Share by Regions (2015-2020)
2.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Growth Strategy
2.3.6 Primary Interviews with Key Epidermal Growth Factor Receptor (EGFR) Inhibitor Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Market Size
3.1.1 Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Revenue (2015-2020)
3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Players (2015-2020)
3.1.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio
3.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2019
3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players Head office and Area Served
3.4 Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service
3.5 Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Type (2015-2020)
4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2021-2026)
5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Application (2015-2026)
5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020)
6.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in North America (2019-2020)
6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020)
6.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
7 Europe
7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020)
7.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Europe (2019-2020)
7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020)
7.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
8 China
8.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020)
8.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in China (2019-2020)
8.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020)
8.4 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
9 Japan
9.1 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020)
9.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Japan (2019-2020)
9.3 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020)
9.4 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020)
10.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020)
10.4 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
11 India
11.1 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020)
11.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in India (2019-2020)
11.3 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020)
11.4 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2015-2020)
12.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Players in Central & South America (2019-2020)
12.3 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020)
12.4 Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Details
13.1.2 Amgen Inc. Business Overview and Its Total Revenue
13.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
13.1.4 Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020))
13.1.5 Amgen Inc. Recent Development
13.2 AstraZeneca Plc
13.2.1 AstraZeneca Plc Company Details
13.2.2 AstraZeneca Plc Business Overview and Its Total Revenue
13.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
13.2.4 AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
13.2.5 AstraZeneca Plc Recent Development
13.3 Eli Lilly and Co.
13.3.1 Eli Lilly and Co. Company Details
13.3.2 Eli Lilly and Co. Business Overview and Its Total Revenue
13.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
13.3.4 Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
13.3.5 Eli Lilly and Co. Recent Development
13.4 F. Hoffmann-La Roche Ltd.
13.4.1 F. Hoffmann-La Roche Ltd. Company Details
13.4.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
13.4.4 F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Ltd. Recent Development
13.5 Novartis AG
13.5.1 Novartis AG Company Details
13.5.2 Novartis AG Business Overview and Its Total Revenue
13.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
13.5.4 Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
13.5.5 Novartis AG Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Market Segments
Table 2. Key Players Covered: Ranking by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue
Table 3. Ranking of Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lung Cancer
Table 6. Key Players of Colorectal Cancer
Table 7. Key Players of Breast Cancer
Table 8. Key Players of Others
Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2015-2020)
Table 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Growth Strategy
Table 19. Main Points Interviewed from Key Epidermal Growth Factor Receptor (EGFR) Inhibitor Players
Table 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Players (2015-2020) (Million US$)
Table 21. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players (2015-2020)
Table 22. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2019)
Table 23. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Solution and Service
Table 26. Date of Enter into Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 29. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2015-2020)
Table 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2021-2026)
Table 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2015-2020)
Table 32. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 33. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2026)
Table 34. North America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020)
Table 36. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 37. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020)
Table 38. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 39. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020)
Table 40. Europe Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020)
Table 42. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020)
Table 44. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020)
Table 46. China Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$)
Table 47. China Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020)
Table 48. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 49. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020)
Table 50. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 51. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020)
Table 52. Japan Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020)
Table 54. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020)
Table 56. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020)
Table 60. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020)
Table 62. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020)
Table 64. India Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$)
Table 65. India Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020)
Table 66. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 67. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020)
Table 68. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 69. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share (2019-2020)
Table 72. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2015-2020)
Table 74. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2015-2020)
Table 76. Amgen Inc. Company Details
Table 77. Amgen Inc. Business Overview
Table 78. Amgen Inc. Product
Table 79. Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$)
Table 80. Amgen Inc. Recent Development
Table 81. AstraZeneca Plc Company Details
Table 82. AstraZeneca Plc Business Overview
Table 83. AstraZeneca Plc Product
Table 84. AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$)
Table 85. AstraZeneca Plc Recent Development
Table 86. Eli Lilly and Co. Company Details
Table 87. Eli Lilly and Co. Business Overview
Table 88. Eli Lilly and Co. Product
Table 89. Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$)
Table 90. Eli Lilly and Co. Recent Development
Table 91. F. Hoffmann-La Roche Ltd. Company Details
Table 92. F. Hoffmann-La Roche Ltd. Business Overview
Table 93. F. Hoffmann-La Roche Ltd. Product
Table 94. F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$)
Table 95. F. Hoffmann-La Roche Ltd. Recent Development
Table 96. Novartis AG Company Details
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Product
Table 99. Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020) (Million US$)
Table 100. Novartis AG Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type: 2020 VS 2026
Figure 2. Lung Cancer Features
Figure 3. Colorectal Cancer Features
Figure 4. Breast Cancer Features
Figure 5. Others Features
Figure 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Research Institutes and Research Institutions Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Epidermal Growth Factor Receptor (EGFR) Inhibitor Report Years Considered
Figure 12. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions: 2020 VS 2026
Figure 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players in 2019
Figure 17. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2019
Figure 19. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Inc. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
Figure 28. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AstraZeneca Plc Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
Figure 30. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Eli Lilly and Co. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
Figure 32. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
Figure 34. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis AG Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed
Keyplayers in Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2020-2026
Amgen Inc.AstraZeneca Plc
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Novartis AG